在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human Kallikrein 6,KLK 6 ELISA Kit

  • 中文名稱:
    人激肽釋放酶6(KLK 6)酶聯免疫試劑盒
  • 貨號:
    CSB-E09248h
  • 規格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產品詳情

  • 產品描述:
    人激肽釋放酶6(KLK 6)酶聯免疫試劑盒(CSB-E09248h)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿樣本中的KLK6含量。KLK6 是一種重要的靶點。它屬于激肽釋放酶家族成員,在神經系統、免疫系統等多種生理過程中發揮作用。目前研究聚焦于其在腫瘤、神經退行性疾病等發病機制里的角色,探索以它為靶點開發診斷標志物或治療藥物。試劑盒檢測范圍為1.25 ng/mL-80 ng/mL,適用于基礎科研中探索KLK6在疾病模型中的表達規律、評估其作為生物標志物的潛力,或用于藥物干預實驗中的動態監測。兼容多種生物樣本類型,包括血清、血漿及組織勻漿,滿足體外實驗中對KLK6蛋白水平的定量分析需求,為神經科學、腫瘤學及分子機制研究提供可靠工具。本品僅用于科研,不用于臨床診斷,產品具體參數及操作步驟詳見產品說明書。
  • 別名:
    Bssp ELISA Kit; hK 6 ELISA Kit; hK6 ELISA Kit; Kallikrein 6 precursor ELISA Kit; Kallikrein related peptidase 6 ELISA Kit; Kallikrein-6 ELISA Kit; Kallikrein6 ELISA Kit; KLK 6 ELISA Kit; Klk 7 ELISA Kit; KLK 9 ELISA Kit; Klk29 ELISA Kit; Klk6 ELISA Kit; KLK6_HUMAN ELISA Kit; Klk7 ELISA Kit; KLK9 ELISA Kit; MGC9355 ELISA Kit; mGK 1 ELISA Kit; mGK1 ELISA Kit; MSP ELISA Kit; Neurosin ELISA Kit; Protease M ELISA Kit; Protease serine 18 ELISA Kit; Protease serine 9 ELISA Kit; PRSS 18 ELISA Kit; PRSS 9 ELISA Kit; PRSS18 ELISA Kit; PRSS9 ELISA Kit; Serine protease 18 ELISA Kit; Serine protease 9 ELISA Kit; SP 59 ELISA Kit; SP59 ELISA Kit; Tissue kallikrein ELISA Kit; TK ELISA Kit; Zyme ELISA Kit
  • 縮寫:
    KLK6
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, tissue homogenates
  • 檢測范圍:
    1.25 ng/mL-80 ng/mL
  • 靈敏度:
    0.31 ng/mL
  • 反應時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領域:
    Cancer
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%      
    Three samples of known concentration were tested twenty times on one plate to assess.  
    Inter-assay Precision (Precision between assays): CV%<10%      
    Three samples of known concentration were tested in twenty assays to assess.    
                 
  • 線性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of human KLK 6 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
      Sample Serum(n=4)  
    1:1 Average % 89  
    Range % 83-95  
    1:2 Average % 95  
    Range % 91-99  
    1:4 Average % 95  
    Range % 88-102  
    1:8 Average % 97  
    Range % 91-101  
  • 回收率:
    The recovery of human KLK 6 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample Type Average % Recovery Range  
    Serum (n=5) 86 80-93  
    EDTA plasma (n=4) 96 92-103  
                 
                 
  • 標準曲線:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/ml OD1 OD2 Average Corrected  
    80 2.819 2.960 2.890 2.737  
    40 2.237 2.205 2.221 2.068  
    20 1.505 1.586 1.546 1.393  
    10 0.799 0.755 0.777 0.624  
    5 0.442 0.411 0.427 0.274  
    2.5 0.313 0.322 0.318 0.165  
    1.25 0.245 0.235 0.240 0.087  
    0 0.154 0.152 0.153    
  • 數據處理:
  • 貨期:
    3-5 working days

產品評價

靶點詳情

  • 功能:
    Serine protease which exhibits a preference for Arg over Lys in the substrate P1 position and for Ser or Pro in the P2 position. Shows activity against amyloid precursor protein, myelin basic protein, gelatin, casein and extracellular matrix proteins such as fibronectin, laminin, vitronectin and collagen. Degrades alpha-synuclein and prevents its polymerization, indicating that it may be involved in the pathogenesis of Parkinson disease and other synucleinopathies. May be involved in regulation of axon outgrowth following spinal cord injury. Tumor cells treated with a neutralizing KLK6 antibody migrate less than control cells, suggesting a role in invasion and metastasis.
  • 基因功能參考文獻:
    1. High KLK6 expression is associated with metastasis of colon cancer. PMID: 30015976
    2. Results showed a significant downregulation of KLK6 mRNA expression in breast cancer (BC) tissue sections compared to the non-cancerous component. The expression of KLK6 is positively associated with tumor grade and is overexpressed in aggressive phenotypes such as TNBC. PMID: 29435805
    3. KLK6-PAR2 expression is down-regulated and PAR1 is up-regulated when DeltaNp63beta expression is decreased, leading to EMT with enhancing migration and invasion through ERK signal reduction at the invasive front PMID: 29224812
    4. KLK6 may be the key protease involved in the proteolytic modification of PFK-M. PMID: 29563071
    5. Our data demonstrate for the first time increased levels of KLK6 in mucosal melanomas of the head and neck PMID: 27844409
    6. Induction of autophagic processes through KLK6 expression may increase acquisition of resistance of gastric cancer cells to auranofin-induced autophagy. PMID: 27863404
    7. Our data provide experimental evidence that KLK6 controls metastasis formation in colon cancer via specific downstream network of miRNA-mRNA effectors. PMID: 28431272
    8. Data show that kallikrein 6 (KLK6) expression is induced in mouse and human skin during chronic glucocorticoid treatment. PMID: 27283773
    9. FST and KLK6 may have significance in breast cancer detection PMID: 27168011
    10. KLK6 overexpression and likely its proteolytic activity is associated with alterations in downstream miRNAs and their targets, and these differ with the molecular subtypes of breast cancer. PMID: 27093921
    11. Molecular models of peptides were built into the KLK6 structure and the marked preference of the cut between the two R of the examined peptides was related to the extended conformation of the substrates PMID: 28254587
    12. Our fine-mapping study has identified novel loci in the KLK6 region strongly associated with aggressive PCa. PMID: 28376164
    13. mRNA expression levels of KLK6 and KLK8 in advanced serous ovarian cancer PMID: 27483364
    14. Data indicate that elevated expression of microRNA-375 in head and neck squamous cell carcinoma (HNSCC) cells significantly reduces kallikrein 6 (KLK6), kallikrein 10 (KLK10), and matrix metalloproteinase 9 (MMP9) messenger RNA expression. PMID: 26172508
    15. KLK6 expression was detected in head and neck tumor cell lines (FaDu, Cal27 and SCC25), but not in HeLa cervix carcinoma cells. PMID: 25990935
    16. The results of this study indicated that reductions in kallikrein-6 and calpain-1 may contribute to the accumulation of alpha-synuclein in DLB. PMID: 25476568
    17. KLK6 and KLK10 may be useful markers and potential therapeutic targets in gastroesophageal junction tumors PMID: 25649006
    18. This study assessed the prognostic utility of human tissue kallikrein-like peptidases 6 and 10 (KLK6 and KLK10) and correlated their expression with histopathological and clinical parameters in gastric cancer. PMID: 25153389
    19. KLK6 may represent a potential unfavorable prognostic biomarker for colon cancer. PMID: 25153391
    20. KLK6 promotes the proliferation of lung tumoral cells and restrains their apoptosis in vitro via ligand-dependent EGFR and was dependent on the protease-activated receptor 2. PMID: 24643912
    21. The level of KLK6 is significantly increased in the plasma samples from laryngeal cancer patients compared to the controls. PMID: 24669031
    22. Our data suggest that de novo KLK6 expression during early liver carcinogenesis may induce production of Ubi(1-74) by post-translational modification of ubiquitin PMID: 24979321
    23. KLK6 mRNA expression could be considered as an independent, unfavorable molecular prognostic biomarker in colorectal adenocarcinoma, with additional prognostic value in patients without regional or distant metastases PMID: 24430362
    24. Data indicate there was no SNP in KLK6 was associated with altered risk of prostate cancer. PMID: 21741862
    25. Neuropathological analysis following delivery of LV-Neurosin to alpha-syn tg mice resulted in reduced accumulation of alpha-syn and reversal of neurodegenerative alterations in wild type but not A53T alpha-syn tg mice PMID: 22508489
    26. Patients with synucleinopathy displayed lower cerebrospinal fluid levels of neurosin and alpha-synuclein compared to controls and Alzheimer's disease patients. PMID: 23308173
    27. KLK6 DNA methylation was significantly associated with pathological stage in prostate cancer patients operated by radical prostatectomy. PMID: 22874102
    28. Decreased serum concentrations of KLK6 are found in patients with aneurysmal subarachnoid hemorrhage, with the lowest levels in patients who died PMID: 23049835
    29. hsa-let-7 family member hsa-let-7a is a modulator of KLK6 protein expression that is independent of the KLK6 copy number status PMID: 23136250
    30. KLK6 gene expression may have clinical utility as a marker of unfavorable prognosis for intracranial tumors, and consequently, it could be used as target for therapeutic intervention. PMID: 22477710
    31. in colorectal cancer patients, lymph node KLK6 positivity indicated presence of aggressive tumour cells associated with poor prognosis and high risk of tumour recurrence PMID: 22699826
    32. KLK6 is positioned to serve as a molecular trigger of select physiological processes involved in the development of astrogliosis PMID: 22505518
    33. KLK6 expressed by stromal cells may considerably contribute to the aggressiveness of ovarian cancer PMID: 22505521
    34. KLK6 is significantly upregulated and secreted in gastric cancer tissues and sera, suggesting that KLK6 might be used as a potential biomarker and therapeutic target for gastric cancer. PMID: 22373580
    35. KLK6 immunostaining is an independent prognostic marker in patients with colorectal carcinoma. PMID: 22285222
    36. High KLK6 is associated with ovarian cancer. PMID: 22102857
    37. KLK6-induced intracellular Ca(2+) flux and tumor cell invasion critically depends on the protease-activated receptor 1 (PAR1). PMID: 21753781
    38. KLK6 has a role in tumour proliferation and progression of NSCLC PMID: 19426157
    39. upregulated in late stage epithelial ovarian cancer PMID: 20680316
    40. KLK6 was up-regulated significantly in tissues and sera from patients with colon cancer and was associated closely with a poor prognosis. PMID: 21656738
    41. KLK6 promotes lymphocyte survival by a mechanism that depends in part on activation of PAR1. PMID: 21464892
    42. The expression of kallikrein 7 and kallikrein 6 in melanomas may be responsible for the loss of cell-cell adhesion. PMID: 21193224
    43. an altered KLK6 expression may contribute to vascular abnormalities in Alzheimer's disease and vascular dementia PMID: 20846516
    44. Neurosin targets extracellular alpha-synuclein in cultured cells. PMID: 20403393
    45. Patients diagnosed with advanced multiple sclerosis showed mean CSF levels of kallikrein-related peptidase 6 (29 ng/ml) that were significantly higher than in neurological controls (25.5 ng/ml). PMID: 20836755
    46. The expression of hK6 in ovarian cancer was higher than that in benign and borderline ovarian neoplasms. Expression is higher in the ovarian cancer of late stage, higher-grade, with lymph node metastasis and is associated with a poorer prognosis. PMID: 19950700
    47. KLK6 expression in cancerous tissues may play an important role in the invasion and metastasis of primary breast carcinoma. PMID: 18992199
    48. Data show that it was unable to distinguish men with and without prostate cancer using multiple kallikreins as urinary biomarkers. PMID: 19560453
    49. characterization of human kallikrein 6 as a degradative protease with structural features more similar to trypsin than the regulatory kallikreins PMID: 11983703
    50. X-ray crystallographic structure of KLK6. PMID: 12016211

    顯示更多

    收起更多

  • 亞細胞定位:
    Secreted. Nucleus, nucleolus. Cytoplasm. Mitochondrion. Microsome. Note=In brain, detected in the nucleus of glial cells and in the nucleus and cytoplasm of neurons. Detected in the mitochondrial and microsomal fractions of HEK-293 cells and released into the cytoplasm following cell stress.
  • 蛋白家族:
    Peptidase S1 family, Kallikrein subfamily
  • 組織特異性:
    In fluids, highest levels found in milk of lactating women followed by cerebrospinal fluid, nipple aspirate fluid and breast cyst fluid. Also found in serum, seminal plasma and some amniotic fluids and breast tumor cytosolic extracts. Not detected in urin
  • 數據庫鏈接:

    HGNC: 6367

    OMIM: 602652

    KEGG: hsa:5653

    STRING: 9606.ENSP00000309148

    UniGene: Hs.79361



主站蜘蛛池模板: 精品国精品无码自拍自在线| 日本熟妇乱人伦xxxx| 欧美综合自拍亚洲图久青草| av性色av久久无码ai换脸| 丰满熟妇被猛烈进入高清片| 中国凸偷窥xxxx自由视频妇科 | 日本三级在线播放线观看视频| 天干夜天干天天天爽视频| 中文在线а天堂中文在线新版| 老司机久久精品最新免费| 奇米777四色成人影视| 夜夜高潮夜夜爽夜夜爱爱一区| 中文字幕无码视频专区| 欧美成人精品三级一二三在线观看 | 久久亚洲国产成人精品无码区 | 奇米777四色在线精品| 日本一道高清一区二区三区| 久久无码字幕中文久久无码| 午夜理论片yy8860y影院| 最新国产精品好看的精品| 67194熟妇在线直接进入| 久久久久九九精品影院| 国产成人a人亚洲精品无码| 色婷婷五月综合欧美图片| 中文字幕一区二区三区乱码| 艳妇乳肉豪妇荡乳xxx| 中文字幕卡二和卡三的视频| 国产精品极品在线拍| 久久伊人蜜桃av一区二区| 国产精品美脚玉足脚交欧美| 中文字幕乱码一区二区免费| 欧洲无码一区二区三区在线观看| 国产96在线 | 欧美| 久久久综合九色合综国产精品| 免费不卡无码av在线观看| 国产精品久久久久久久久久久免费看| 天堂资源中文网| 久久久久四虎精品免费入口| 一道本在线伊人蕉无码| 国产日韩综合一区二区性色av| 久久精品成人免费国产片小草|